Sopheon, the InnovationOps software company, announces that following the exercise of options by certain employees it has allotted 3,500 new Ordinary Shares of 20 pence each in the Company (“Ordinary Shares”) which have been purchased by the Company’s Employee Benefit Trust.
Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 5 April 2023.
The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,634,892. The Company does not hold any shares in treasury. Accordingly, the figure of 10,634,892 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information contact:
| Andy Michuda (Executive Chairman) Arif Karimjee (CFO) |
Sopheon plc | + 44 (0) 1276 919 560 |
| Carl Holmes/Abigail Kelly / George Dollemore (Corporate Finance) Alice Lane / Sunila de Silva (ECM) |
finnCap | + 44 (0) 20 7220 0500 |
About Sopheon
Sopheon (LSE: SPE) empowers organizations to change the world while achieving exceptional long-term revenue growth and profitability. By operationalizing the entire innovation life cycle, Accolade® and Acclaim™ software and expertise enable innovation, product and project professionals to accomplish the full range of InnovationOps tasks to drive innovation at scale. Sopheon’s industry leadership was highlighted in the comprehensive MarketsandMarkets™ report on the Innovation Management market, in which Sopheon was listed in the “Stars” category, the highest recognition. Sopheon’s solutions have been implemented by hundreds of blue-chip customers with over 125,000 users in 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange.